Skip to main content

Replicating the Findings of a Medicare Study on Stroke, and Bleeding Risk in Patients Using NOACs for Atrial Fibrillation in the Sentinel System

Basic Details
Date
Type
Presentation
Materials

Replicating the Findings of a Medicare Study on Stroke, and Bleeding Risk in Patients Using NOACs for Atrial Fibrillation in the Sentinel System

Information
Host

36th International Conference on Pharmacoepidemiology & Therapeutic Risk Management

Related Assessment(s)
36th International Conference on Pharmacoepidemiology and Therapeutic Risk Management
Stroke, Intracranial Hemorrhage, and Bleeding following Dabigatran, Rivaroxaban, and Apixaban Use in Patients Aged 65 or Older: A Propensity Score Matched Analysis
ICPE All Access Conference Abstracts
Sentinel Drug Study: Eliquis (Apixaban), Pradaxa (Dabigatran), and Xarelto (Rivaroxaban) & Gastrointestinal Bleeding, Intracranial Hemorrhage, Major Extracranial Bleeding, and Thromboembolic Stroke
Presenter(s)

Marie Bradley, Emily C. Welch, Mayura Shinde, Efe Eworuke, Rongmei Zhang, Elande Baro, David J. Graham